These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24035907)

  • 41. Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor.
    Grisouard J; Medunjanin S; Hermani A; Shukla A; Mayer D
    Mol Endocrinol; 2007 Oct; 21(10):2427-39. PubMed ID: 17609434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct molecular regulation of glycogen synthase kinase-3alpha isozyme controlled by its N-terminal region: functional role in calcium/calpain signaling.
    Azoulay-Alfaguter I; Yaffe Y; Licht-Murava A; Urbanska M; Jaworski J; Pietrokovski S; Hirschberg K; Eldar-Finkelman H
    J Biol Chem; 2011 Apr; 286(15):13470-80. PubMed ID: 21266584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas.
    Atkins RJ; Dimou J; Paradiso L; Morokoff AP; Kaye AH; Drummond KJ; Hovens CM
    J Clin Neurosci; 2012 Nov; 19(11):1558-63. PubMed ID: 22999562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Issues associated with the use of phosphospecific antibodies to localise active and inactive pools of GSK-3 in cells.
    Campa VM; Kypta RM
    Biol Direct; 2011 Jan; 6():4. PubMed ID: 21261990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TNF-α expression in neutrophils and its regulation by glycogen synthase kinase-3: a potentiating role for lithium.
    Giambelluca MS; Bertheau-Mailhot G; Laflamme C; Rollet-Labelle E; Servant MJ; Pouliot M
    FASEB J; 2014 Aug; 28(8):3679-90. PubMed ID: 24803542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A noncatalytic domain of glycogen synthase kinase-3 (GSK-3) is essential for activity.
    Buescher JL; Phiel CJ
    J Biol Chem; 2010 Mar; 285(11):7957-63. PubMed ID: 20080974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Constitutive glycogen synthase kinase-3alpha/beta activity protects against chronic beta-adrenergic remodelling of the heart.
    Webb IG; Nishino Y; Clark JE; Murdoch C; Walker SJ; Makowski MR; Botnar RM; Redwood SR; Shah AM; Marber MS
    Cardiovasc Res; 2010 Aug; 87(3):494-503. PubMed ID: 20299330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of PKB/SGK-dependent phosphorylation of GSK-3α/β in vascular calcification during cholecalciferol overload in mice.
    Tuffaha R; Voelkl J; Pieske B; Lang F; Alesutan I
    Biochem Biophys Res Commun; 2018 Sep; 503(3):2068-2074. PubMed ID: 30119888
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte.
    Kim SD; Yang SI; Kim HC; Shin CY; Ko KH
    Brain Res; 2007 Dec; 1186():12-20. PubMed ID: 17996850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain.
    Yao HB; Shaw PC; Wong CC; Wan DC
    J Chem Neuroanat; 2002 May; 23(4):291-7. PubMed ID: 12048112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GSK-3α/β-mediated phosphorylation of CRMP-2 regulates activity-dependent dendritic growth.
    Tan M; Ma S; Huang Q; Hu K; Song B; Li M
    J Neurochem; 2013 Jun; 125(5):685-97. PubMed ID: 23470087
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GSK-3beta and control of glucose metabolism and insulin action in human skeletal muscle.
    Ciaraldi TP; Carter L; Mudaliar S; Henry RR
    Mol Cell Endocrinol; 2010 Feb; 315(1-2):153-8. PubMed ID: 19505532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of glycogen synthase kinase-3β with Parkinson's disease (review).
    Li DW; Liu ZQ; Chen W; Yao M; Li GR
    Mol Med Rep; 2014 Jun; 9(6):2043-50. PubMed ID: 24681994
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polarized regulation of glycogen synthase kinase-3β is important for glioma cell invasion.
    Zou Q; Hou Y; Shen F; Wang Y
    PLoS One; 2013; 8(12):e81814. PubMed ID: 24312592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression analysis of glycogen synthase kinase-3 in human tissues.
    Lau KF; Miller CC; Anderton BH; Shaw PC
    J Pept Res; 1999 Jul; 54(1):85-91. PubMed ID: 10448973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in sperm glycogen synthase kinase-3 serine phosphorylation and activity accompany motility initiation and stimulation.
    Somanath PR; Jack SL; Vijayaraghavan S
    J Androl; 2004; 25(4):605-17. PubMed ID: 15223849
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GSK-3α/β Activity Negatively Regulates MMP-1/9 Expression to Suppress
    Zhou X; Lie L; Liang Y; Xu H; Zhu B; Huang Y; Zhang L; Zhang Z; Li Q; Wang Q; Han Z; Huang Y; Liu H; Hu S; Zhou C; Wen Q; Ma L
    Front Immunol; 2021; 12():752466. PubMed ID: 35095838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibitory phosphorylation of GSK-3 by CaMKII couples depolarization to neuronal survival.
    Song B; Lai B; Zheng Z; Zhang Y; Luo J; Wang C; Chen Y; Woodgett JR; Li M
    J Biol Chem; 2010 Dec; 285(52):41122-34. PubMed ID: 20841359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glycogen synthase kinase-3 phosphorylates CdGAP at a consensus ERK 1 regulatory site.
    Danek EI; Tcherkezian J; Triki I; Meriane M; Lamarche-Vane N
    J Biol Chem; 2007 Feb; 282(6):3624-31. PubMed ID: 17158447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glycogen Synthase Kinase-3α Promotes Fatty Acid Uptake and Lipotoxic Cardiomyopathy.
    Nakamura M; Liu T; Husain S; Zhai P; Warren JS; Hsu CP; Matsuda T; Phiel CJ; Cox JE; Tian B; Li H; Sadoshima J
    Cell Metab; 2019 May; 29(5):1119-1134.e12. PubMed ID: 30745182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.